Dapaconazole
- Generic Name
- Dapaconazole
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H15Cl2F3N2O
- CAS Number
- 1269726-67-1
- Unique Ingredient Identifier
- H2976538CX
- Background
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
- Associated Conditions
- -
- Associated Therapies
- -
Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Galeno Desenvolvimento de Pesquisas Clínicas
- Target Recruit Count
- 51
- Registration Number
- NCT03359070
- Locations
- 🇧🇷
Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas, SP, Brazil
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
- First Posted Date
- 2017-10-25
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Biolab Sanus Farmaceutica
- Target Recruit Count
- 360
- Registration Number
- NCT03320486
- Locations
- 🇧🇷
Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas, SP, Brazil
Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Gilberto De Nucci
- Target Recruit Count
- 60
- Registration Number
- NCT02824926
Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Biolab Sanus Farmaceutica
- Registration Number
- NCT02606383
- Locations
- 🇧🇷
Clínica Gobbato de Dermatologia, Rio Claro, São Paulo, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath